Of every 300 people infected with HIV, one doesn’t get AIDS. Under-standing this uncanny protection might help science imitate nature.
Prototypes play well with humans, helping patients with autism and Alzheimer’s. But don’t expect an army of such aides just yet.
They work without employees, fancy offices or big incomes. But back-to-basics doctors cite one elusive perk: satisfaction.
The brain, it turns out, can heal itself, and adding stem cells could unleash that power to treat Parkinson’s, stroke and even depression.
How science can play a leading role in reversing the nation’s economic meltdown, by Peter L. Slavin and David F. Torchiana.
Readers suggest ER improvements and challenge Proto’s take on case-control studies.
A simple technology nets a decline in malaria incidence and deaths.
Risk expert David Ropeik argues that despite constant headlines, Americans' health worries are largely misplaced.
In 13 states, a doctor's note will get you a "prescription" to puff.
Drug naming is serious business for the pharmaceutical industry, and names must be catchy enough to stick in an ever-expanding market.
In 1849 Elizabeth Blackwell became the first woman to graduate from medical school.
New studies aim to determine what consumers do—or don't do—after they've had a mail-order genome test.
Surfing the Web, restoring vision and calling on the Bee Gees to save lives.
A unique shape could hold the key to repairing heart tissue.
A rare tumor places the author in an uncomfortable spotlight.